Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 88%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,765
Total Claims
$2.3M
Drug Cost
1,222
Beneficiaries
$1,919
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-28%
Opioid rate vs peers
1.6% vs 2.2% avg
+36%
Cost per patient vs peers
$1,919 vs $1,411 avg
+2%
Brand preference vs peers
10.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
369
Opioid Claims
$22K
Opioid Cost
18.4%
Long-Acting Rate
Brand vs Generic
Brand: 2,446 claims · $1.7M
Generic: 20,219 claims · $687K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 217 | $271K |
| Empagliflozin | 229 | $263K |
| Dulaglutide | 147 | $192K |
| Apixaban | 168 | $152K |
| Fluticasone/Umeclidin/Vilanter | 97 | $95K |
| Tirzepatide | 79 | $92K |
| Rivaroxaban | 63 | $54K |
| Fluticasone/Vilanterol | 78 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 67 | $42K |
| Semaglutide | 29 | $39K |
| Emtricitabine/Tenofovir (Tdf) | 22 | $37K |
| Fluticasone Propion/Salmeterol | 44 | $31K |
| Linaclotide | 29 | $30K |
| Atorvastatin Calcium | 1,288 | $29K |
| Lisdexamfetamine Dimesylate | 60 | $27K |
Prescribing Profile
Patient Profile
74
Avg Age
51%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About